These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30763744)

  • 1. Postoperative Confusion in Patients with Parkinson Disease Undergoing Deep Brain Stimulation of the Subthalamic Nucleus.
    Paim Strapasson AC; Martins Antunes ÁC; Petry Oppitz P; Dalsin M; de Mello Rieder CR
    World Neurosurg; 2019 May; 125():e966-e971. PubMed ID: 30763744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgressing the ventricular wall during subthalamic deep brain stimulation surgery for Parkinson disease increases the risk of adverse neurological sequelae.
    Gologorsky Y; Ben-Haim S; Moshier EL; Godbold J; Tagliati M; Weisz D; Alterman RL
    Neurosurgery; 2011 Aug; 69(2):294-9; discussion 299-300. PubMed ID: 21389886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for postoperative urinary retention after deep brain stimulation surgery: the role of the subthalamic nucleus.
    Porche K; Peart R; Silva V; Mampre D; Chandra V; Zakare-Fagbamila R; Foote K; Hilliard JD; Robicsek S
    J Neurosurg; 2024 Jul; 141(1):221-229. PubMed ID: 38306648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed-onset seizures after subthalamic nucleus deep brain stimulation surgery for Parkinson's disease.
    Wu B; Liu J; Jiang L; Xu J; Xuan R; Ling Y; Guo Q; Jiang N; Chen L; Zhang C
    J Clin Neurosci; 2024 Jun; 124():81-86. PubMed ID: 38669906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative MRI for optimizing electrode placement for deep brain stimulation of the subthalamic nucleus in Parkinson disease.
    Cui Z; Pan L; Song H; Xu X; Xu B; Yu X; Ling Z
    J Neurosurg; 2016 Jan; 124(1):62-9. PubMed ID: 26274983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Postoperative Confusion and Prolonged Hospital Stay Following Deep Brain Stimulation Surgery for Parkinson Disease.
    Abboud H; Genc G; Saad S; Thompson N; Oravivattanakul S; Alsallom F; Yu XX; Floden D; Gostkowski M; Ahmed A; Ezzeldin A; Marouf HM; Mansour OY; Fernandez HH
    Neurosurgery; 2020 Apr; 86(4):524-529. PubMed ID: 31432068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease.
    Qureshi AA; Cheng JJ; Sunshine AN; Wu A; Pontone GM; Cascella N; Lenz FA; Grill SE; Anderson WS
    Neurosurg Focus; 2015 Jun; 38(6):E5. PubMed ID: 26030705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between subthalamic nucleus deep brain stimulation and weight gain: Results of a case-control study.
    Strowd RE; Herco M; Passmore-Griffin L; Avery B; Haq I; Tatter SB; Tate J; Siddiqui MS
    Clin Neurol Neurosurg; 2016 Jan; 140():38-42. PubMed ID: 26619034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic, non-infectious, non-hemorrhagic edema after subthalamic nucleus deep brain stimulation surgery for Parkinson's disease.
    Nazzaro JM; Pahwa R; Lyons KE
    J Neurol Sci; 2017 Dec; 383():42-46. PubMed ID: 29246619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical Complications in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease: Experience in 800 Patients.
    Holewijn RA; Wiggerts Y; Bot M; Verbaan D; de Bie RMA; Schuurman R; van den Munckhof P
    Stereotact Funct Neurosurg; 2024; 102(5):275-283. PubMed ID: 38934196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the effects of unilateral electrode dysfunction in patients with Parkinson disease undergoing bilateral subthalamic nucleus deep brain stimulation.
    Park YS; Kim JP; Chang WS; Lee PH; Sohn YH; Chang JW
    Neurosurgery; 2012 Mar; 70(1 Suppl Operative):163-9; discussion 169. PubMed ID: 21768919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid protein markers in PD patients after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001.
    Constantinescu R; Blennow K; Rosengren L; Eriksson B; Gudmundsdottir T; Jansson Y; Johnels B; Renck A; Bergquist F
    Clin Neurol Neurosurg; 2018 Nov; 174():174-179. PubMed ID: 30248592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship of Electrophysiologic Subthalamic Nucleus Length as a Predictor of Outcomes in Deep Brain Stimulation for Parkinson Disease.
    Shenai MB; Patel DM; Romeo A; Whisenhunt JD; Walker HC; Guthrie S; Guthrie BL
    Stereotact Funct Neurosurg; 2017; 95(5):341-347. PubMed ID: 28982098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved cognition after deep brain stimulation (DBS) in the subthalamic area for Parkinson's disease: a case report.
    Cyron D; Funk M; Deletter MA; Scheufler K
    Acta Neurochir (Wien); 2010 Dec; 152(12):2097-100. PubMed ID: 20676703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.